More people should be taking statins for primary prevention, US study suggests US guidelines that set the threshold for starting statin therapy at a lower level than the threshold recommended by the National Institute for Health and Care Excellence in England are cost effective, say researchers.…
Clinical Pharmacist’s monthly news round-up: the top 10 in the past month What has been happening in the world of pharmacy? Here’s our pick of must-read news from the past month.…
Studies linking statins and memory loss may be flawed Researchers suggest that detection bias may be the reason why statins have been associated with memory impairment.…
England’s top doctor orders review into how medicines are evaluated The chief medical officer for England has ordered an independent review into the efficacy and safety of medicines to address a growing perception that doctors and scientists are “untrustworthy”.…
Statins could increase lung cancer survival Data show slight reduction in deaths from lung cancer in statin users, but further research is needed to make a firm conclusion.…
Prescribing statins: time to rein it in Statins have been overprescribed for decades for many different reasons. Now is the time to reverse the trend.…
Finnish study explores association between statin use and diabetes Researchers have shown that statin use increases the risk of type 2 diabetes and suggest that the higher risk is due to decreases in insulin sensitivity and insulin secretion.…
Statins increase risk of type 2 diabetes, study suggests The use of statins increases the risk of developing type 2 diabetes by 46%, even after adjusting for confounding factors, according to a study published in Diabetologia.…
Genetic risk for coronary events linked to statin response Patients with high and intermediate genetic risk for coronary heart disease benefit more from statin therapy than patients at low genetic risk, researchers have shown.…
UK data confirm protective effect of statins against liver cancer A study using data from the UK has observed a protective effect of statins against liver cancer, an effect previously seen in countries with high rates of the disease.…
